IQ Capital

IQ Capital maintains embedded relationships with university research departments, deploying scouts and advisors within the Maxwell Centre at Cambridge, Imperial College London and Oxford's Begbroke Science Park. This allows the firm to identify PhD-founded startups before they reach mainstream accelerators. The team performs technical due diligence directly on academic research, often leading pre-seed and seed rounds where competitors lack the engineering expertise to evaluate the technology credibly.

IQ Capital's partnership is staffed by former engineers and researchers who assess deals on technical merit first. Unlike generalist firms that rely on market-sizing exercises, IQ Capital evaluates molecular biology protocols, semiconductor architectures or quantum error-correction algorithms as part of routine diligence. This capability underpins an investment strategy concentrated entirely on deeptech sectors—AI/ML, quantum computing, cybersecurity, advanced materials, synthetic biology and space technology—where the founders hold PhDs or equivalent research credentials.

No. While seed and Series A represent the firm's core activity, IQ Capital operates a dedicated growth-stage vehicle—IQ Capital Growth Fund—that writes $15–30 million cheques into later-stage portfolio companies. This internal follow-on structure allows the firm to retain significant ownership positions through Series C and beyond, reducing dilution from external growth investors. The combined platform covers pre-seed through late-stage expansion within the same deeptech mandate.

Day-to-day investment decisions are led by Managing Partners Kerry Baldwin and Max Bautin, who co-founded the firm in 2006. Simon Thorpe, former Managing Director at Investcorp Technology Partners, serves as Chairman and provides strategic oversight. The partnership operates a consensus-driven investment committee; specific voting structures and individual check-size authorities are not publicly disclosed.

Based on its observed portfolio and published mandate, IQ Capital does not invest in consumer internet, e-commerce, digital media, hospitality or pure software-as-a-service plays without a defensible hard-science or engineering moat. The firm's capital is reserved for companies where intellectual property originates in university research or corporate R&D labs, effectively excluding business-model innovation plays that dominate generalist venture portfolios.

Initial cheques range from £1 million to £10 million at seed and Series A, with reserves allocated for multiple follow-on rounds. The firm's growth-stage vehicle provides additional firepower of $15–30 million for portfolio companies reaching commercial scale. This approach ensures portfolio companies retain access to insider capital across their full lifecycle, a structural advantage over seed-only funds that must syndicate growth rounds to external players.

IQ Capital is an independent private partnership with no legal or financial affiliation to the University of Cambridge. The commercial relationship is one of proximity and embedded scouting—the firm places personnel within Cambridge research centres to identify investment opportunities. Fund IV raised capital from institutional LPs including the European Investment Fund and British Patient Capital; none of the firm's limited partners include the University of Cambridge endowment.